The novaxomx GmbH is a joint venture between Curasan AG and Xlife Sciences AG. The aim is to research and develop exosomes for use in musculoskeletal diseases. novaxomx has signed a license agreement with Lysatpharma for the use of exosomes. novaxomx develops exosomes for applications in regenerative medicine, such as bone regeneration